Beruflich Dokumente
Kultur Dokumente
So Paulo, SP
December, 2016
Public1
All forward-looking statements in this presentation are based on information and data available as of the date they
were made, and BM&FBOVESPA undertakes no obligation to update them in light of new information or future
development.
This presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall
there be any sale of securities where such offer or sale would be unlawful prior to registration or qualification
under the securities law. No offering shall be made except by means of a prospectus meeting the requirements of
the Brazilian Securities Commission CVM Instruction 400 of 2003, as amended.
2
OPERATIONAL PERFORMANCE
Notable global exchange
FINANCIAL HIGHLIGHTS
Cost discipline and capital return to shareholders
3Q16 RESULTS
APPENDIX
3
Exchange sector
Safety and market integrity as priorities
Capital and derivatives markets in Brazil
Main participants
Listed companies
Investors institutional, foreign and
individual (retail)
1967:
Bovespas
Mutualization
1986:
Start of
BM&F
activities
Aug 2007:
Bovespa Hld
demutualization
Oct 2007:
Bovespa Hld
IPO (BOVH3)
Nov 2007:
BM&F IPO
(BMEF3)
May 2008:
Merger between BM&F and Bovespa
Hld and creation of BM&FBOVESPA
(BVMF3)
to the market
Post-trading Platform:
EQUITY
CASH
INTEREST
FX
OPTIONS
FUTURE
POST-TRADE
Listing
COMMODITIES
FORWARD
Securities lending
CREDIT
Indices Licensing
Software Licensing
OTC (derivatives and fixed income)
6
USA
TRADING
DTCC
Brokers A and B
Brokers A and B
Broker
A
Broker
B
POST-TRADING
CCP
SSS
CSD
Investors
Investors
Investors
Investors
Corporate governance
Reference in corporate governance practices
Solid Governance Practices
10%
7%
5%
2%
76%
Oppenheimer Funds
BlackRock Funds
Treasury stock
Others
Note: percentage ownership are estimated but may not represent exact figures
due to different information dates about largest shareholders positions
Corporate Governance
Multidisciplinary knowledge in conducting business
2015-17 Board of Directors Composition
Birth
Years
in the
Board
2/21/53
8/23/46
Board Member
Committees
Antnio Quintella
Former CEO of CS Brasil and Americas; Portfolio Manager
2/16/66
8/11/60
6/9/70
1/15/64
11/18/45
4/14/63
10/7/58
9/10/66
Charles P. Carey
Former Chairman of CBOT; CME Group Board Member
9/1/53
Independent
members
Board
Audit
Nomination
and CG
Comp.
Risk
Brokerage
Industry
11
Independent Board
Independent Non-Board
14
14
94%
82%
100%
92%
80%
93%
# Members
# of meetings (2015)
Average attendance (2015)
Linked to
market participant or
strategic partner (CME)
Note: in the case of the Advisory Committee for the Securities Intermediation Industry the statistics
regarding number of meetings and attendance considered the previous composition with 6 members,
including two Board members. This change was implemented in Feb 2015.
Corporate Governance
Multidisciplinary knowledge in conducting business
Management and Internal Governance
Board of
Directors
Internal Audit
CEO
Edemir Pinto
Corporate Risk
Human Resources
Sustainability,
Press and Mkt.
CIO
Rodrigo Nardoni
Luis Furtado
CPO
Jos Ribeiro de
Andrade
Financial, Legal,
IR and Issuer
Regulation
Trading, Risk
Management,
Clearing,
Settlement,
Depository,
BVMF Bank and
Market
Participants
Relationship
Products and
Business
Develop.,
Commercial
Relations,
Internat. Offices,
Commercial
Planning and
Project Analysis
4 MDs
6 MDs
5 MDs
6 MDs
CFO
Daniel Sonder
COO
Ccero Vieira
Advisory Committees
Market Advisory
Chambers
The Head of the Audit Department reports functionally to the Board of Directors and the Audit Committee. The Audit Committee may periodically assess the performance of the Head of Audit
Department, after consulting the Executive Board. Co-Chief Information Officer. In May, Mr. Furtado resigned from the statutory position of Chief Technology and Information Security Officer with
effect from the end of his current mandate on April 30, 2017.
10
11
OPERATIONAL PERFORMANCE
Notable global exchange
FINANCIAL HIGHLIGHTS
Cost discipline and capital return to shareholders
3Q16 RESULTS
APPENDIX
12
DERIVATIVES MARKET
Growth of credit and fixed-rate government debt: higher demand for
hedging from financial institutions and institutional investors
Growth of foreign trade: higher demand for hedging through FX contracts
Equities market development: growth in demand for index-based contracts
OTC derivatives: capital requirements (Basel) should benefit OTC
transactions through a CCP
13
14
OPERATIONAL PERFORMANCE
Notable global exchange
FINANCIAL HIGHLIGHTS
Cost discipline and capital return to shareholders
3Q16 RESULTS
APPENDIX
15
BM&FBOVESPA is investing
more than R$ 1.6 billion (2010 2016) to build state-of-the-art
IT, Risk and Operating
infrastructure
NEW
DATA CENTER
Source: BM&FBOVESPA.
17
4 rulebooks and
4 manuals.
Other products
and assets
4 participant
structures
4 distinct
environments /
IT architectures
4 settlement
windows and 4
multilateral
balances
4 systems /
back-office
processes
Government
Bonds
Rules and Manuals
Corporate
fixed income
Position control
Clearing and settlement
4 systems /
processes for risk
management
4 registration
systems for
participants and
clients.
4 pools of
collateral
Risk management
Pool of collateral
Securities
lending
Interbank spot
foreign
exchange
Futures, options,
forwards
Liquidity management
improvement
More efficient
allocation of capital by
investors
Operational and
technological risk
reduction
18
What we did
The achievements
What is next
19
Source: BM&FBOVESPA.
20
FINANCIAL HIGHLIGHTS
Cost discipline and capital return to shareholders
3Q16 RESULTS
APPENDIX
21
22
Law 13.043 grants exemption on capital gains for eligible SMEs investors until 2023
Creation of investment fund with proper structure to invest in SMEs
Reduction of maintenance and public offer cost for listed companies
Include stocks in the roll of restricted public distribution efforts
BNDES support to foster IPOs on BOVESPA MAIS
Fixed Income and OTC markets (product, market and revenue diversification)
Securities registration: (i) marketing of already-available products (CDB, LCA, LCI and COE); ii)
new products (CDB - new types, Financial Bills, COE - physical delivery and repos)
OTC Derivatives: (i) benefits of CORE; (ii) SWAPs and Flexible Options migration to the new
platform (flexibility and operational efficiency); and (iii) development of SWAPs with cash flow
Corporate bonds: (i) acceptance of securities with restricted distribution efforts (ICVM 476);
and (ii) migration of trading to PUMA
Constant fee structure and incentive improvements
Use of pricing policies and incentives as important tools for the development of products,
markets and services, as well as alignment with market participants
Review and monitoring of existing pricing and incentives policies
23
OPERATIONAL PERFORMANCE
Notable global exchange
FINANCIAL HIGHLIGHTS
Cost discipline and capital return to shareholders
3Q16 RESULTS
APPENDIX
24
Updated to November 30, 2016 Ratio of cash equities trading volume to the overall market capitalization
25
2008
2009
2010
2011
2012
2013
2015
2016
D-15
J-16
F-16
M-16
A-16
M-16
J-16
J-16
A-16
S-16
O-16
N-16
1.171
1.471
1.065
1.159
1.193
1.251
1.208
1.213
1.201
1.394
1.222
0.993
1.095
FX rates
3.855
4.507
4.524
4.483
4.285
4.136
3.846
3.902
3.533
3.518
3.455
3.434
3.291
Stock Indices
1.804
2.265
1.667
2.212
1.561
2.143
1.545
2.017
1.454
1.906
1.505
1.975
1.405
1.829
1.892
2.128
2.100
2.225
1.879
1.960
1.877
1.523
1.608
1.555
1.616
1.528
Commodities
2.238
2.734
2.451
2.591
2.247
1.890
2.298
2.024
1.981
2.255
2.728
2.293
2.047
Mini contracts
0.248
0.276
0.276
0.281
0.259
0.276
0.268
0.264
0.242
0.240
0.241
0.235
0.203
OTC
45.662
Total RPC
1.318
1.940
1.484
1.526
1.480
1.517
1.363
1.380
1.229
1.285
1.229
1.100
1.044
Updated to November 30, 2016. Starting from Jan/16 excludes OTC data.
2014
26
Updated to November 30, 2016. Starting from Jan/16 excludes OTC data.
27
OPERATIONAL PERFORMANCE
Notable global exchange
FINANCIAL HIGHLIGHTS
Cost discipline and capital return to shareholders
3Q16 RESULTS
APPENDIX
28
Income Statement
History of income statement results (consolidated)
(in BRL thousand)
2009
2010
2011
2012
Net revenue
1,510,569
1,898,742
1,904,684
2,064,750
Expenses
(569,832)
(633,504)
(816,664)
(763,080)
(790,814) (804,070)
(850,656)
(446,677)
(543,881)
(584,521)
(563,487)
(575,763) (592,349)
(614,350)
940,737
1,265,238
1,088,020
1,301,670
Operating margin
62.3%
66.6%
57.1%
63.0%
62.8%
60.4%
61.6%
38,238
219,461
149,270
171,365
212,160
136,245
245,837
289,039
280,729
208,851
180,695
208,157
508,796
1,186,574
1,592,515
1,588,210
1,659,791
(304,505)
(448,029)
(539,681)
(585,535)
(606,588) (660,959)
(603,764)
881,050
1,144,561
1,047,999
1,074,290
1,080,947
2,202,238
1,223,761
1,586,374
1,545,627
1,612,136
0.6104
0.7929
0.7932
0.8351
Adjusted expenses
Operating income
Financial result
Net income
Adjusted net income
Adjusted EPS (BRL)
2013
0.8389
2014
977,053
0.8048
2015
1.0152
29
2017 budget
2017e vs. 2016e: 5.34%4
INVESTMENTS BUDGET:
Investment program initiated in 2010 reaching its conclusion
FX exposure: ~38%
Main projects
Phase 2 (equity) of BM&FBOVESPA
Clearinghouse
Update of PUMA Trading System
infrastructure
New Data Center
Expenses adjusted to the Companys (i) depreciation and amortization; (ii) costs from stock grant plan principal and payroll taxes and stock option; (iii) transaction cost and planning of the proposed
business combination with Cetip, that is still pending regulatory approval; and (iv) provisions, transfer of fines and incentive programs to market participants. Considers the mid-point of 2016 budget.
IPCA for 2016 and 2017 based on median market expectations released by the Brazilian Central Bank on Dec. 02, 2016. 4 Considers the mid-point of 2017 budget and 2016 budget.
30
Expenses Discipline
Delivering efficiency through diligent expense management
-11.2%
Third party
services
3.2%
-6.7%
Marketing
5.7%
-4.5%
-57.0%
-61.1%
Total
Personnel 2
Data
processing
-1.8%
Real Change3
18.5%
-11.5%
Data
processing
-3.8%
Nominal
Change
16.9%
-11.5%
1,8%
Third party
services
Total
Personnel 2
3.9%
(in R$ millions)
-20.8%
-40.0%
Marketing
Real Change3
-69.1%
-76.6%
Communicat.
Nominal
Change
Communicat.
-75.0%
-81.0%
IPCA last 12 months until Dec15 (Source IBGE) 2 Includes personnel expenses and capitalization and excludes costs from stock grant plan principal and payroll taxes stock option and
31
bonus expenses. 3 Calculated based on the annual wage increase for personnel expenditure and the accumulated IPCA for the other lines of expenses.
Allocation of Results
Return of surplus capital to shareholders
+
Share Buyback
Data of BM&FBOVESPA (not consolidated): excludes variation in financial transactions and collateral pledged by participants, proceeds raised in connection with the acquisition of CME Group shares in 2010 and
32
the divestment from CME Group shares in Sep/15 and Apr/16. 50% of the net income excluding the impact from the sale of CME Group shares in Apr/16.
OPERATIONAL PERFORMANCE
Notable global exchange
FINANCIAL HIGHLIGHTS
Cost discipline and capital return to shareholders
3Q16 RESULTS
APPENDIX
33
Financial highlights
3Q16 (vs. 3Q15)
BM&F Segment:
Bovespa Segment:
ADTV: R$6.93 bn, +5.9%
Strategic updates
Proposed business combination
with Cetip
Pending regulatory approval: CVM,
Central Bank and CADE (filed with
CADE on June 28, 2016)
Efforts on planning the integration
1 Adjusted
to (i) depreciation and amortization; (ii) stock grant plan costs principal and payroll taxes and stock option plan; (iii) transaction cost and planning of the proposed business combination with Cetip
that is still pending regulatory approval; and (iv) transfer of fines, provisions and incentive programs to market participants. Attributable to BM&FBOVESPAs shareholders. 3 Depending on test results and
34
regulatory approval.
Total
revenue
R$621.3 mn
The revenue breakdown considers the revenue lines others of the Bovespa Segment and foreign exchange and securities of BM&F Segment, as reported in the financial
statements note 20, within the other revenues not tied to volumes. Trading and post-trading.
35
Derivatives market
Revenue impacted by lower ADV and RPC
REVENUE (in R$ millions)
3Q15
3Q16
YoY
1,791
1,206
-32.7%
FX rates
473
386
-18.3%
Stock indices
101
79
-22.2%
321
229
-28.7%
-2.2%
597
997
66.9%
3,293
2,906
-11.7%
Commodities
Mini contracts
TOTAL
% tot.
BM&F
rev.
Revenue does not consider the revenue lines foreign exchange and securities of the BM&F Segment, as reported in the financial statements note 20, which totaled R$4.6
million in 3Q16. Most of the fees charged on FX rate, Interest rates in USD and Commodities contracts are referred in USD. The average BRL/USD exchange rate appreciated 4.7%
from 3Q15 to 3Q16.
36
Equities market
Higher volumes contributed to the revenue increase
REVENUE (in R$ millions)
3Q16 HIGHLIGHTS
6.545,1
5,246
3Q16
6.930,9
YoY
5,9%
Revenue does not consider the revenue line others of Bovespa Segment, as reported in the financial statements note 20, which totaled R$4.5 million in the 3Q16. Excludes
fixed income line.
37
22.4%
3Q16
YoY
Depository
47.4
31.1%
Securities lending
30.2
6.8%
24.6
-19.2%
Listing
13.1
-0.7%
9.9
-1.3%
8.7
-12.6%
Other
5.1
-18.9%
Total
138.9
3.5%
38
3Q16 expenses
Continued focus on expense management
ADJUSTED EXPENSES (in R$ millions)
3Q16 adjusted expenses decreased 5.0% YoY
Adjusted
personnel
(-3.3%): annual
wage
adjustment of
~9% offset
mainly by
higher
capitalization
Data
processing
(+21.3%):
inflation/FX
rate
adjustments to
IT maintenance
contracts
Third party
(+14.2%):
higher
expenses with
consultancy
services
Marketing
(-64.1%): in
3Q15,
expenses
connected to
the
organization of
the Financial
Markets
Conference
Others
(-21.0%): in
3Q15, nonrecurring writeoff of R$6.4 mn
3Q16
84.1 (54%)
36.9 (24%)
14.4 (9%)
1.7 (1%)
18.4 (12%)
3Q15
87.0 (53%)
30.4 (19%)
12.6 (8%)
4.7 (3%)
28.9 (18%)
Adjusted to (i) depreciation and amortization; (ii) stock grant plan costs principal and payroll taxes and stock option plan; (iii) transaction costs and planning of the business combination with Cetip that is
still pending regulatory approval; and (iv) transfer of fines, provisions and incentive programs to market participants. Excluding the impact of stock grant/option expenses. Include expenses with
communication, maintenance, taxes, board and committee members compensation and other.
39
Before tax
After tax
Expenses
183.9
121.4
Expenses
47.4
33.6
Expenses
7.2
4.7
238.5
159.7
(in R$ millions)
Total
Pending regulatory approvals from CVM, Central Bank and Antitrust Authority CADE. Includes expenses with legal reports, auditors, appraisers, and lawyers, among other
professionals engaged as advisors for the transaction as well as the planning of the integration.
40
Financial highlights
Increase in financial revenue reflecting higher cash balance
FINANCIAL RESULT (in R$ millions)
FINANCIAL RESULT OF R$221.5 MILLION, +157.5% YoY
Includes gains from changes in the exchange rate as well as other financial revenue. Includes maintenance of stand-by facilities, available but not drawn, in connection with the transaction with Cetip.
Effective rate 6.47% per year, after withholding income tax.
41
3Q16
10,718
2Q16
10,463
1Q16
5,661
4Q15
5,202
3Q15
8,164
Third-party cash
Third-party
Total
Includes earnings and rights on securities in custody. Includes BM&FBOVESPA Bank clients deposits. Does not include investments in Bolsa Mexicana de Valores, Bolsa de Comercio de Santiago and
Bolsa de Valores de Colombia amounting R$203.1 million at 3Q16 and booked as financial investments. See note 4 to the financial statements. 4 Pending regulatory approvals from CVM, Central Bank and
Antitrust Authority CADE.
42
3Q16
513.1
672.3
-37.7
-40.6
-61.8
-64.8
413.6
566.9
Cash generation before dividends/IoC payments and share buybacks. Considers the cash flow from operating activities, adjusted by the variation of financial investments and guarantees and cash
deposits and REPO transactions of the BM&FBOVESPA bank, as described in the note 13 to the financial statements. Considers the cash flow from financing activities before the payment of
dividends/IoC and share buyback. 4 Pending regulatory approvals from CVM, Central Bank and Antitrust Authority CADE.
43
2017
April, 8th
BVMF and
Cetips
Boards
approved the
financial
terms for the
transaction
May, 20th
Oct, 13th
Jun, 28th
Nov, 14th
Feb, 23rd
We are here
Request to analyze the
act of concentration
was filed in CADE
CADE deadline
(240-day)
CADE considered
complex the
concentration act of
the combination
May, 24th
The final
deadline for
CADE approvals
(if extended)
This measure
allows CADE to
extend the
deadline for more
90 days
44
Financial Statements
Summary of balance sheet (consolidated)
ASSETS (in R$ millions)
Current assets
Cash and cash equivalents
Financial investments
Others
Non-current assets
9,067.6
8,673.8
546.8
440.8
8,210.9
7,798.5
310.0
434.4
18,085.0
17,635.1
09/30/2016 12/31/2015
Current liabilities
3,497.5
2,096.8
1,605.6
1,338.0
Others
1,891.9
758.8
Non-current liabilities
5,038.3
5,859.9
1,993.7
2,384.1
2,617.1
3,272.3
427.5
203.5
18,616.8
18,352.2
2,540.2
2,540.2
14,284.7
14,300.3
1,782.1
1,501.6
9.7
10.1
27,152.6
26,308.9
2,335.9
2,162.8
1,815.6
Others
173.2
145.8
Investments
29.5
30.6
455.2
453.1
15,264.3
15,190.0
Goodwill
14,401.6
Total Assets
27,152.6
Long-term receivables
Financial investments
Others
Shareholders equity
Capital stock
Capital reserve
Others
45
Financial Statements
Net income and adjusted expenses reconciliations
ADJUSTED NET INCOME RECONCILIATION (in R$ millions)
3Q16
IRFS net income*
Stock grant/option (recurring net of tax)
Deferred tax liabilities
Equity in Income of Investees (net of taxes)
Expenses related to Cetips transaction (net of tax)
Divestment in CME Group shares (net of tax)
IOF on proceeds from CME Group shares sale (net of tax)
IoC Adjustments
Discontinuity of the equity method (net of taxes)
Results from the selling of the CME Group (net of taxes)
Non-recurring expenses with provisions (net of tax)
Adjusted net income
*Attributable to BM&FBOVESPA shareholders.
293.5
13.9
135.3
0.0
4.7
0.0
0.0
0.0
0.0
0.0
155.0
602.4
3Q15
2,012.5
12.8
137.5
(37.6)
0.0
0.0
0.0
(49.0)
(1,145.0)
(474.2)
0.0
457.0
Change
3Q16/3Q15
-85.4%
8.6%
-1.6%
31.8%
2Q16
(114.4)
27.2
135.3
0.0
31.5
557.3
10.8
0.0
0.0
0.0
0.0
647.7
Change
3Q16/2Q16
-356.5%
-48.8%
0.0%
-85.0%
-7.0%
9M16
518.4
57.9
405.9
(19.6)
36.9
557.3
10.8
0.0
0.0
0.0
155.0
1,722.5
9M15
2,610.0
37.6
412.6
(106.8)
0.0
0.0
0.0
(49.0)
(1,145.0)
(474.2)
0.0
1,285.1
Change
9M16/9M15
-80.1%
53.9%
-1.6%
-81.7%
34.0%
446.1
(25.1)
(21.1)
(0.7)
(6.5)
(237.3)
155.5
3Q15
217.8
(26.1)
(19.4)
0.0
0.0
(8.7)
163.6
Change
3Q16/3Q15
104.8%
-3.8%
8.6%
2634.8%
-5.0%
2Q16
268.8
(23.8)
(41.2)
(46.3)
(1.5)
(9.4)
146.7
Change
3Q16/2Q16
66.0%
5.8%
-48.8%
-98.5%
324.4%
2431.8%
6.0%
9M16
917.0
(72.7)
(87.7)
(48.0)
(8.0)
(254.1)
446.5
9M15
637.3
(84.8)
(84.9)
0.0
0.0
(23.6)
443.9
Change
9M16/9M15
43.9%
-14.3%
3.3%
975.6%
0.6%
Includes expenses with legal reports. auditors. appraisers. and lawyers. among other professionals engaged as advisors for the transaction. Includes expenses with consulting services hired to help
the integration planning of the proposed combination with Cetip which is subject to regulatory approvals
46
Financial Statements
Summary of the income statement (consolidated)
SUMMARY OF THE INCOME STATEMENT (in R$ millions)
3Q16
Net revenues
3Q15
Change
3Q16/3Q15
559.1
598.3
(446.1)
(217.8)
113.0
380.5
-70.3%
20.2%
63.6%
-4,338 bps
Financial result
221.5
Expenses
Operating income
Operating margin
Adjusted expenses
-6.5%
2Q16
Change
3Q16/2Q16
9M16
9M15
Change
9M16/9M15
574.5
-2.7%
1,697.1
1,673.4
1.4%
104.8% (268.8)
66.0%
(917.0)
(637.3)
43.9%
305.7
-63.0%
780.2
1,036.1
-24.7%
53.2%
-3,300 bps
46.0%
61.9%
-1,595 bps
86.0
157.5% (418.3)
-153.0%
(36.2)
219.0
-116.5%
293.5
2,012.5
-85.4% (114.4)
-356.5%
518.4
2,610.0
-80.1%
(155.5)
(163.6)
-5.0% (146.7)
6.0%
(446.5)
(443.9)
0.6%
47
OPERATIONAL PERFORMANCE
Notable global exchange
FINANCIAL HIGHLIGHTS
Cost discipline and capital return to shareholders
3Q16 RESULTS
APPENDIX
48
ETFs
Securities Lending
(Open Interest - average for the period - in BRL billion)
49
Bovespa Segment
Raising Capital
PUBLIC OFFERINGS (BRL billion)
50
Novo Mercado
Launch
(Dec. 2000)
Sarbanes-Oxley Act
(Jul. 2002)
Nov16
25.1%
9.0%
34.1%
33.2%
32.7%
65.9%
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
1
7
9
26
64
4
6
11
11
3
10
1
1
1
14
5
8
8
10
16
12
8
18
11
11
9
7
1
4
8
14
6
8
15
19
42
76
12
24
22
22
12
17
2
5
9
Dual Listings
Total
155
150
305
5
51
Bovespa Segment
Foreign investment flow
MONTHLY NET FLOW OF FOREGIN INVESTMENTS (in BRL billions)
Includes public offering (primary market) and regular trades (secondary market).
52
Readjustment of
Issuers annual fee
Rebalancing
Trading/post-trade
Prices p/ volume
Tiers in
Derivatives
2008
Charge (BPs) on
amount in
depository
Price policy for
Mkt Data
2009
2010
2011
Transfers fee
structure at CSD
Equities Market
Fee Structure
2012
Organizational
Structure for Fee
Structure
2013
2014
2015
Fee Structure of
OTC Products
Fee structure of
interest rate
derivatives
Review of prices and
incentives: BTC, DMA,
Market Data, Issuers and
Depository
53
1. DETERMINING
THE CLOSEOUT
STRATEGY
T+0
T+1
T+2
T+3
T+4
...
T+N
2. RISK EVALUATION
T+0
T+1
T+2
T+3
T+4
...
T+N
T+1
T+2
T+3
T+4
CLOSEOUT RISK
PERMANENT LOSS
TRANSIENT LOSS
...
3. POTENTIAL P&L
CALCULATION
T+0
T+N
54
Contato
www.bmfbovespa.com.br
55 11 2565-4729 / 4418 / 4207/4834/7938
ri@bmfbovespa.com.br
55